Veterinary Medicines

Mastijet Forte suspensija ievadīšanai tesmenī laktējošām govīm

Authorised
  • Chlortetracycline hydrochloride
  • Neomycin
  • Bacitracin
  • Prednisolone
Download as PDF

Product identification

Medicine name:
Mastijet Forte suspensija ievadīšanai tesmenī laktējošām govīm
Active substance:
  • Chlortetracycline hydrochloride
  • Neomycin
  • Bacitracin
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Chlortetracycline hydrochloride
    200.00
    milligram(s)
    /
    1.00
    Syringe
  • Neomycin
    250.00
    milligram(s)
    /
    1.00
    Syringe
  • Bacitracin
    2000.00
    international unit(s)
    /
    1.00
    Syringe
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        14
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/96/0344
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 6/09/2024
Download